Drug maker Ranbaxy Laboratories today reported a drop of 25% in its consolidated profit after tax (PAT) of Rs 243 crore for the second quarter ended June 30, 2011.
The company had a PAT of Rs 326 crore in the same period previous fiscal, Ranbaxy Laboratories said in a statement.
The company's consolidated net sales stood at Rs 2,060 crore for the second quarter ended June 30, 2011. It was Rs 2,095 crore in the same period last financial year.
Commenting on the results Ranbaxy Managing Director Arun Sawhney said: "We have consciously worked towards strengthening our base business on the one hand and successfully delivering on multiple first to file opportunities on the other."
Shares of Ranbaxy were trading at Rs 515.5 on BSE in late afternoon trade, down 3.5% from its previous close.
